NANTHEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5922 USD | +44.44% |
|
+53.06% | +37.72% |
| Apr. 23 | NantHealth, Inc. Announces the Appointment of Marc Harrison as Chief Legal Officer | CI |
| Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 326.2 | 59.58 | 113.9 | 359.2 | 121.8 | 28.12 |
| Enterprise Value (EV) 1 | 460 | 241.8 | 328 | 559.4 | 351.2 | 293.8 |
| P/E ratio | -2.03 x | -0.31 x | -1.8 x | -6.31 x | -2.07 x | -0.41 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.76 x | 0.67 x | 1.19 x | 4.91 x | 1.94 x | 0.42 x |
| EV / Revenue | 5.31 x | 2.7 x | 3.42 x | 7.65 x | 5.61 x | 4.38 x |
| EV / EBITDA | -8.54 x | -5.69 x | -17.2 x | -27.7 x | -10 x | -6.46 x |
| EV / FCF | -9.57 x | -12 x | 59.5 x | -35.3 x | -18.2 x | -15.2 x |
| FCF Yield | -10.4% | -8.33% | 1.68% | -2.83% | -5.5% | -6.59% |
| Price to Book | 1.71 x | 21 x | -1.99 x | -3.22 x | -0.75 x | -0.12 x |
| Nbr of stocks (in thousands) | 7,130 | 7,299 | 7,375 | 7,414 | 7,696 | 7,703 |
| Reference price 2 | 45.75 | 8.163 | 15.45 | 48.45 | 15.82 | 3.650 |
| Announcement Date | 3/16/18 | 4/1/19 | 2/28/20 | 2/26/21 | 2/25/22 | 4/14/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 86.68 | 89.46 | 95.96 | 73.17 | 62.65 | 67 |
| EBITDA 1 | -53.85 | -42.47 | -19.06 | -20.2 | -35.05 | -45.46 |
| EBIT 1 | -67.9 | -50.7 | -26.79 | -25.54 | -40.9 | -51.33 |
| Operating Margin | -78.34% | -56.67% | -27.92% | -34.9% | -65.28% | -76.61% |
| Earnings before Tax (EBT) 1 | -133.6 | -194.1 | -62.76 | -87.99 | -58.47 | -68.1 |
| Net income 1 | -175.2 | -192.2 | -62.76 | -56.33 | -58.26 | -67.78 |
| Net margin | -202.14% | -214.78% | -65.4% | -76.98% | -92.99% | -101.16% |
| EPS 2 | -22.51 | -26.40 | -8.566 | -7.675 | -7.656 | -8.800 |
| Free Cash Flow 1 | -48.05 | -20.13 | 5.51 | -15.84 | -19.33 | -19.36 |
| FCF margin | -55.44% | -22.5% | 5.74% | -21.65% | -30.85% | -28.89% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/16/18 | 4/1/19 | 2/28/20 | 2/26/21 | 2/25/22 | 4/14/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Net sales 1 | 16.09 | 14.36 | 16.03 | 16.37 | 16.5 | 16.63 |
| EBITDA | -4.688 | - | - | - | - | - |
| EBIT | -8.59 | -11.07 | -11.86 | -12.49 | -11.71 | - |
| Operating Margin | -53.39% | -77.11% | -74.01% | -76.26% | -71% | - |
| Earnings before Tax (EBT) | -15.44 | -10.88 | -16.63 | -15.93 | -12.54 | - |
| Net income | -15.3 | -10.84 | -16.7 | -15.95 | -12.51 | - |
| Net margin | -95.11% | -75.51% | -104.21% | -97.42% | -75.84% | - |
| EPS | -1.950 | -1.350 | -2.100 | -2.100 | -1.650 | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/5/21 | 11/4/21 | 2/24/22 | 5/5/22 | 8/5/22 | 11/4/22 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 134 | 182 | 214 | 200 | 229 | 266 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.485 x | -4.29 x | -11.23 x | -9.911 x | -6.545 x | -5.843 x |
| Free Cash Flow 1 | -48.1 | -20.1 | 5.51 | -15.8 | -19.3 | -19.4 |
| ROE (net income / shareholders' equity) | -43.4% | -194% | 231% | 105% | 42.8% | 35% |
| ROA (Net income/ Total Assets) | -7.49% | -8.62% | -6.06% | -6.84% | -12.8% | -18% |
| Assets 1 | 2,340 | 2,230 | 1,036 | 823.6 | 453.7 | 377.5 |
| Book Value Per Share 2 | 26.80 | 0.3900 | -7.750 | -15.10 | -21.00 | -29.30 |
| Cash Flow per Share 2 | 8.530 | 2.510 | 0.7100 | 3.070 | 3.780 | 0.2300 |
| Capex 1 | 13.6 | 10.5 | 4.59 | 5.67 | 5.08 | 6.47 |
| Capex / Sales | 15.73% | 11.79% | 4.78% | 7.75% | 8.11% | 9.66% |
| Announcement Date | 3/16/18 | 4/1/19 | 2/28/20 | 2/26/21 | 2/25/22 | 4/14/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +37.72% | 19.31M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- NHIQ Stock
- Financials NantHealth, Inc.
